These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2455303)

  • 1. [Inoperable bronchial carcinoma. 2. Effect of gender, age, general condition and tumor stage on survival time after intensive radiotherapy].
    Oehler W; Lessel A; Hüttner J
    Radiobiol Radiother (Berl); 1988; 29(1):11-7. PubMed ID: 2455303
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inoperable bronchial carcinoma. 3. Behavior of the primary tumor in the roentgen image--prognostic value after intensive radiotherapy].
    Oehler W
    Radiobiol Radiother (Berl); 1988; 29(1):19-26. PubMed ID: 2455304
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inoperable bronchial carcinoma. 4. Radiation effect on the primary tumor--autopsy histological findings after intensive radiotherapy].
    Oehler W; Lessel A
    Radiobiol Radiother (Berl); 1988; 29(1):27-32. PubMed ID: 2455305
    [No Abstract]   [Full Text] [Related]  

  • 4. Pretreatment classification and staging of bronchogenic carcinoma.
    Larsson S
    Scand J Thorac Cardiovasc Surg Suppl; 1973; ():1-147. PubMed ID: 4358671
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term clinical benefits of the low dose rate endobronchial irradiation of malignant airway obstructions.
    Spásová I; Petera J
    Neoplasma; 2001; 48(3):234-40. PubMed ID: 11583295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognosis of inoperable bronchial carcinomas managed through a combination of cytostatic- and radiotherapy].
    Zimmermann G; Heyszl G; Boeckl O; Karrer K; Laszcz M; Steiner H
    Zentralbl Chir; 1974 Jun; 99(22):690-4. PubMed ID: 4136424
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
    Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
    J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Standards, Options and Recommendations for the management of stage I or II primary bronchial cancers treated exclusively with radiotherapy].
    Touboul E; Lagrange JL; Theobald S; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Bréchot J; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Le Chevalier T; Lemarie E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stoebner-Delbarre A; Thiberville L; Vaylet F; Vergnon JM; Westeel V; Depierre A
    Cancer Radiother; 2001 Aug; 5(4):452-63. PubMed ID: 11521393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of concurrent chemoradiotherapy for inoperable (bulky) stage III (A/B) non-small cell lung cancer (NSCLC): a preliminary report.
    Ratanatharathorn V; Lorvidhaya V; Kraipiboon P; Sirachainan E; Maoleekoonpairoj S; Phromratanapongse P; Cheirsilpa A; Tangkaratt S; Srimuninnimit V; Pattaranutaporn P; Lertsanguansinchai P
    J Med Assoc Thai; 2000 Jan; 83(1):85-92. PubMed ID: 10710874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early results of cytostatic treatment supplementing high-voltage radiotherapy of inoperable small-cell bronchial carcinoma].
    Fess W; Schmidt N; Schmidt-Hermes HJ
    Strahlentherapie; 1974 Dec; 148(6):560-3. PubMed ID: 4141518
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of curative and palliative radiotherapy efficacy in unresectable advanced non-small cell lung cancer patients with or without metastasis.
    Unlu I; Diniz G; Komurcuoglu B; Gayaf M; Gokce T; Karadogan I; Akcay C
    Saudi Med J; 2006 Jun; 27(6):849-53. PubMed ID: 16758049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Curative radiotherapy of unresectable bronchial cancer. Apropos of 266 cases without metastasis with 4 to 6 years follow-up (oat cell carcinoma excluded)].
    Baillet F; Maulard C; Dessard-Diana B; Manoux D; Housset M; Alapetite C; Michel-Langlet P; Delanian S
    Ann Med Interne (Paris); 1989; 140(5):353-5. PubMed ID: 2556953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients.
    Ozkok S; Karakoyun-Celik O; Goksel T; Mogulkoc N; Yalman D; Gok G; Bolukbasi Y
    Lung Cancer; 2008 Dec; 62(3):326-33. PubMed ID: 18482780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Brachytherapy in the treatment of lung and tracheal cancer: current indications, methods, results].
    Skowronek J; Młynarczyk W; Piorunek T
    Przegl Lek; 2006; 63(8):664-73. PubMed ID: 17441380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of the TNM system for the comparison of results of x-ray and cobalt teletherapy in unoperable bronchial carcinoma].
    Franke HD; Haug HP; Stephan G
    Strahlentherapie; 1967 Feb; 132(2):161-72 contd. PubMed ID: 4175222
    [No Abstract]   [Full Text] [Related]  

  • 18. High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy.
    Chang JY; Komaki R; Sasaki R; Liao Z; Stevens CW; Lu C; Fossella FV; Allen PK; Cox JD; Spitz MR; Wu X
    Clin Cancer Res; 2005 Apr; 11(8):2894-8. PubMed ID: 15837739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug therapy in bronchial carcinoma].
    Manegold C; Drings P
    Schweiz Med Wochenschr; 1995 Jul; 125(29):1396-405. PubMed ID: 7545824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer.
    Zhao L; West BT; Hayman JA; Lyons S; Cease K; Kong FM
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):103-10. PubMed ID: 17363189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.